F2RL3 and prostate cancer: Moreover, Han et al. showed that, in prostate cancer cells treated with BCG, there was an increase in PAR-4 activation as a defense against mycobacteria, which in turn led to ER stress-induced apoptosis through intracellular ROS generation and the activation of caspases [18].